Abstract
Neuromuscular monitoring is not a routine practice in clinical settings worldwide. The little interest expressed is mainly because clinicians lack information and documentation, even though the literature on the subject is vast and experts agree that routine monitoring reduces morbidity related to the use of neuromuscular blockers. We report a case of an unusual phase II neuromuscular block from a subclinical dose of succinylcholine. The blockade lasted longer than expected in a patient with diminished plasma cholinesterase activity. We emphasize that monitoring neuromuscular function aided diagnosis and observation of the block during emergency surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
